Molly Levine

Implementation of a point mutation assay for HIV drug resistance testing in Kenya

Ingrid A. Beck, B. Chohan, L. Frenkel, 2018, AIDS.

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013–2014

Ingrid A. Beck, B. Chohan, B. Richardson, 2017, The Journal of infectious diseases.

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

Ingrid A. Beck, B. Chohan, J. Kiarie, 2020, EClinicalMedicine.

Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru.

Ingrid A. Beck, E. Ticona, S. León, 2019, AIDS research and human retroviruses.

Comparison of Matrix-Based and Filter Paper-Based Systems for Transport of Plasma for HIV-1 RNA Quantification and Amplicon Preparation for Genotyping

Ingrid A. Beck, L. Frenkel, G. Pepper, 2016, Journal of Clinical Microbiology.

Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial.

Ingrid A. Beck, B. Chohan, J. Kiarie, 2019, The lancet. HIV.

A Randomized Clinical Trial Evaluating the Management of Pre-Treatment HIV Drug Resistance by Oligonucleotide Ligation Assay

B. Chohan, J. Kiarie, R. Coombs, 2019 .

Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy

J. Kiarie, Wenjie Deng, M. Chung, 2022, AIDS.